Role of CD44 expressed in renal tubules during maladaptive repair in renal fibrogenesis in an allopurinol‐induced rat model of chronic kidney disease
- 24 October 2023
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (3) , 455-469
Abstract
The kidney is a major target organ for the adverse effects of pharmaceuticals; renal tubular epithelial cells (TECs) are particularly vulnerable to drug‐induced toxicity. TECs have regenerative capacity; however, maladaptive repair of TECs after injury leads to renal fibrosis, resulting in chronic kidney disease (CKD). We previously reported the specific expression of CD44 in failed‐repair TECs of rat CKD model induced by ischemia reperfusion injury. Here, we investigated the pathophysiological role of CD44 in renal fibrogenesis in allopurinol‐treated rat CKD model. Dilated or atrophic TECs expressing CD44 in fibrotic areas were collected by laser microdissection and subjected to microarray analysis. Gene ontology showed that extracellular matrix (ECM)‐related genes were upregulated and differentiation‐related genes were downregulated in dilated/atrophic TECs. Ingenuity Pathway Analysis identified CD44 as an upstream regulator of fibrosis‐related genes, including Fn1, which encodes fibronectin. Immunohistochemistry demonstrated that dilated/atrophic TECs expressing CD44 showed decreases in differentiation markers of TECs and clear expression of mesenchymal markers during basement membrane attachment. In situ hybridization revealed an increase in Fn1 mRNA in the cytoplasm of dilated/atrophic TECs, whereas fibronectin was localized in the stroma around these TECs, supporting the production/secretion of ECM by dilated/atrophic TECs. Overall, these data indicated that dilated/atrophic TECs underwent a partial epithelial–mesenchymal transition (pEMT) and that CD44 promoted renal fibrogenesis via induction of ECM production in failed‐repair TECs exhibiting pEMT. CD44 was detected in the urine and serum of APL‐treated rats, which may reflect the expression of CD44 in the kidney.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (21KD2003)
This publication has 60 references indexed in Scilit:
- Intragraft Tubular Vimentin and CD44 Expression Correlate With Long-Term Renal Allograft Function and Interstitial Fibrosis and Tubular AtrophyTransplantation, 2010
- Gene set-level network analysis using a toxicogenomics databaseGenomics, 2010
- The Japanese toxicogenomics project: Application of toxicogenomicsMolecular Nutrition & Food Research, 2010
- New Insights into Epithelial-Mesenchymal Transition in Kidney FibrosisJournal of the American Society of Nephrology, 2010
- The epidemiology of drug-induced disorders: the kidneyExpert Opinion on Drug Safety, 2008
- Identifying genetic risk factors for serious adverse drug reactions: current progress and challengesNature Reviews Drug Discovery, 2007
- Soluble CD44 Is a Potential Marker for the Early Detection of Head and Neck CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- Ischemia-reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitroAmerican Journal of Physiology-Renal Physiology, 2004
- CD44 in glomerulonephritis: Expression in human renal biopsies, the Thy 1.1 model, and by cultured mesangial cellsKidney International, 1996
- Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritisKidney International, 1996